Class Certification Denied For Contaminated Statin Drug
TRENTON, N.J. — A New Jersey federal judge on Nov. 13 denied certification of a class action alleging that consumers received a cholesterol drug made by generic manufacturer Ranbaxy Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article